These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2687897)

  • 21. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease.
    Crimi E; Orefice U; De Benedetto F; Grassi V; Brusasco V
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):501-8. PubMed ID: 7788518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
    Andrasch R; Schmitz-Schumann M
    Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
    Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
    Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of fominoben and oxyethyltheophylline in combination on pulmonary function and pulmonary hemodynamics in chronic-obstructive diseases of the airways (author's transl)].
    Siemon G; Thoma R
    Arzneimittelforschung; 1978; 28(4):698-700. PubMed ID: 155459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of theophylline in nonasthmatic airway obstruction.
    Schmidt R; Altschuler S
    Angiology; 1979 Nov; 30(11):744-9. PubMed ID: 389103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction.
    Dolcetti A; Osella D; De Filippis G; Carnuccio C; Grossi E
    J Int Med Res; 1988; 16(4):264-9. PubMed ID: 3169372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in a double-blind crossover experiment on chronic obstructive bronchopneumopathy].
    Iaia E
    Boll Chim Farm; 1990; 129(10-11):60S-67S. PubMed ID: 2102704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a short course of treatment with acebrophylline on the mucus rheological characteristics and respiratory function parameters in patients suffering from chronic obstructive pulmonary disease.
    Agliati G
    J Int Med Res; 1996; 24(3):302-10. PubMed ID: 8725993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of theophylline in treatment of chronic obstructive pulmonary disease].
    Barg W; Kraus-Filarska M
    Pneumonol Alergol Pol; 1997; 65 Suppl 1():71-6. PubMed ID: 9410306
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease.
    Kirsten DK; Wegner RE; Jörres RA; Magnussen H
    Chest; 1993 Oct; 104(4):1101-7. PubMed ID: 8404175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ventilatory effect and side effects of oral bamifylline].
    Minette A
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):211-21. PubMed ID: 552146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation of respiratory function and blood gas analysis in patients with obstructive bronchopneumopathy in acute or stabilized chronic phase].
    Schiavina M; Bernardi E; Faenza S; Festa C; Petrini F; Vissicchio D; Martinelli G
    Minerva Anestesiol; 1990 Oct; 56(10):1257-8. PubMed ID: 2290559
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness and tolerance of a new molecule with secreto-dynamic activity: nesosteine].
    Gatto PG; Gramolini C; Valenti S
    Clin Ter; 1989 Jan; 128(2):87-97. PubMed ID: 2523778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.